AGÕæÈ˹ٷ½

STOCK TITAN

[424B2] Morgan Stanley Prospectus Supplement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
424B2
Rhea-AI Filing Summary

Morgan Stanley Finance LLC is offering Buffered PLUS—principal-at-risk structured notes—due 3 August 2028, linked to the Dow Jones Industrial Average (INDU), S&P 500 (SPX) and Russell 2000 (RTY). Each $1,000 note delivers no periodic interest and is an unsecured obligation of MSFL, fully guaranteed by Morgan Stanley.

Pay-off mechanics rely on the worst-performing underlier on the single observation date (31 July 2028):

  • If every index closes above its initial level, the investor receives principal + leveraged upside: $1,000 × [1 + (163%â€�173%) × % gain of the worst performer].
  • If any index finishes at or below its initial but at or above 90 % of it, only par ($1,000) is returned.
  • If any index closes below 90 % of its initial level, repayment equals principal × (performance factor + 10 %), imposing a 1 : 1 loss beyond the 10 % buffer, subject to a minimum redemption of $100 (10 %).

Key terms

  • Issue price: $1,000; estimated value at pricing: â‰� $962.10 (reflects embedded issuance, structuring and hedging costs).
  • Leverage factor: to be fixed at 163 %â€�173 % on 31 July 2025 strike/pricing date.
  • Buffer: 10 % downside protection on each index.
  • Distribution: sold through fee-based advisory accounts; dealers may earn up to $6.25/note structuring fee; MS &Co. will not receive a sales commission.
  • Liquidity: not exchange-listed; secondary market, if any, made solely by MS &Co. at its discretion.
  • CUSIP/ISIN: 61778NCZ2 / US61778NCZ24.

Principal risks highlighted by the issuer include:

  • Exposure to credit risk of Morgan Stanley/MSFL; notes are unsecured and unsubordinated.
  • No periodic income; return depends solely on terminal index performance.
  • Concentration in worst-performing index negates diversification; a single index drop below buffer triggers losses.
  • Market value likely below issue price after launch owing to embedded costs and use of an internal funding rate advantageous to the issuer.
  • Limited liquidity and potential wide bid/offer spreads.
  • Tax treatment uncertain; counsel expects prepaid financial contract, but IRS could disagree.

The product targets investors who are bullish to neutral on all three indices over a three-year horizon, can tolerate significant downside risk, and value a modest buffer alongside leveraged participation in capped equity upside.

Morgan Stanley Finance LLC propone Buffered PLUS—note strutturate con capitale a rischio—con scadenza al 3 agosto 2028, collegate al Dow Jones Industrial Average (INDU), al S&P 500 (SPX) e al Russell 2000 (RTY). Ogni nota da $1.000 non paga interessi periodici ed è un obbligazione non garantita di MSFL, completamente garantita da Morgan Stanley.

Meccanismo di rimborso basato sul sottostante con la performance peggiore alla data di osservazione unica (31 luglio 2028):

  • Se tutti gli indici chiudono sopra il livello iniziale, l'investitore riceve capitale + rendimento amplificato: $1.000 × [1 + (163%â€�173%) × % di guadagno del peggior indice].
  • Se un indice termina al livello iniziale o sopra il 90% di esso, viene restituito solo il valore nominale ($1.000).
  • Se un indice chiude sotto il 90% del livello iniziale, il rimborso sarà pari a capitale × (fattore di performance + 10%), con una perdita 1:1 oltre il buffer del 10%, con un rimborso minimo di $100 (10%).

Termini principali

  • Prezzo di emissione: $1.000; valore stimato al pricing: circa $962,10 (inclusi costi di emissione, strutturazione e copertura).
  • Fattore di leva: fissato tra 163% e 173% il 31 luglio 2025, data di strike/pricing.
  • Buffer: protezione al ribasso del 10% su ciascun indice.
  • Distribuzione: venduto tramite conti di consulenza a tariffa; i dealer possono ricevere fino a $6,25 per nota come commissione di strutturazione; MS & Co. non riceverà commissioni di vendita.
  • ³¢¾±±ç³Ü¾±»å¾±³Ùà: non quotato in borsa; il mercato secondario, se presente, sarà gestito esclusivamente da MS & Co. a propria discrezione.
  • CUSIP/ISIN: 61778NCZ2 / US61778NCZ24.

Rischi principali evidenziati dall'emittente includono:

  • Esposizione al rischio di credito di Morgan Stanley/MSFL; le note sono non garantite e non subordinate.
  • Nessun reddito periodico; il rendimento dipende esclusivamente dalla performance finale degli indici.
  • Concentrazione sul peggior indice che annulla la diversificazione; un calo di un solo indice sotto il buffer comporta perdite.
  • Valore di mercato probabilmente inferiore al prezzo di emissione dopo il lancio, a causa dei costi incorporati e dell'uso di un tasso di finanziamento interno favorevole all'emittente.
  • Liquidità limitata e possibili ampi spread denaro-lettera.
  • Trattamento fiscale incerto; si prevede un contratto finanziario prepagato, ma l'IRS potrebbe avere un'opinione diversa.

Il prodotto è rivolto a investitori con un outlook rialzista o neutrale sui tre indici in un orizzonte triennale, che possono tollerare rischi significativi al ribasso e apprezzano un buffer moderato insieme a una partecipazione leva con upside azionario limitato.

Morgan Stanley Finance LLC ofrece Buffered PLUS—notas estructuradas con principal en riesgo—con vencimiento el 3 de agosto de 2028, vinculadas al Dow Jones Industrial Average (INDU), S&P 500 (SPX) y Russell 2000 (RTY). Cada nota de $1,000 no paga intereses periódicos y es una obligación no garantizada de MSFL, totalmente respaldada por Morgan Stanley.

Mecánica de pago basada en el activo subyacente con peor desempeño en la única fecha de observación (31 de julio de 2028):

  • Si todos los índices cierran por encima de su nivel inicial, el inversor recibe principal + ganancia apalancada: $1,000 × [1 + (163%â€�173%) × % de ganancia del peor índice].
  • Si algún índice termina en o por encima del 90% de su nivel inicial, solo se devuelve el valor nominal ($1,000).
  • Si algún índice cierra por debajo del 90% de su nivel inicial, el reembolso será principal × (factor de rendimiento + 10%), con una pérdida 1:1 más allá del buffer del 10%, con un reembolso mínimo de $100 (10%).

Términos clave

  • Precio de emisión: $1,000; valor estimado en precio: aproximadamente $962.10 (incluye costos de emisión, estructuración y cobertura).
  • Factor de apalancamiento: fijado entre 163% y 173% el 31 de julio de 2025, fecha de strike/precio.
  • Buffer: protección a la baja del 10% en cada índice.
  • ¶Ù¾±²õ³Ù°ù¾±²ú³Ü³¦¾±Ã³²Ô: vendido a través de cuentas de asesoría con tarifa; los distribuidores pueden ganar hasta $6.25 por nota como comisión de estructuración; MS & Co. no recibirá comisión de venta.
  • Liquidez: no cotizado en bolsa; el mercado secundario, si existe, será realizado únicamente por MS & Co. a su discreción.
  • CUSIP/ISIN: 61778NCZ2 / US61778NCZ24.

Riesgos principales señalados por el emisor incluyen:

  • Exposición al riesgo crediticio de Morgan Stanley/MSFL; las notas son no garantizadas y no subordinadas.
  • No hay ingresos periódicos; el retorno depende únicamente del desempeño final de los índices.
  • Concentración en el índice de peor desempeño que elimina la diversificación; una caída de un solo índice bajo el buffer provoca pérdidas.
  • Valor de mercado probablemente inferior al precio de emisión tras el lanzamiento debido a costos incorporados y uso de una tasa interna de financiamiento favorable para el emisor.
  • Liquidez limitada y posibles amplios spreads entre oferta y demanda.
  • Tratamiento fiscal incierto; se espera un contrato financiero prepagado, pero el IRS podría no estar de acuerdo.

El producto está dirigido a inversores con una perspectiva alcista a neutral en los tres índices en un horizonte de tres años, que pueden tolerar riesgos significativos a la baja y valoran un buffer moderado junto con participación apalancada en una subida limitada del mercado accionario.

Morgan Stanley Finance LLCëŠ� 2028ë…� 8ì›� 3ì� 만기ì� Buffered PLUS—ì›ê¸� 위험 구조í™� ì¦ê¶Œì� 제공하며, Dow Jones Industrial Average (INDU), S&P 500 (SPX), Russell 2000 (RTY) ì§€ìˆ˜ì— ì—°ë™ë©ë‹ˆë‹�. ê°� $1,000 노트ëŠ� 정기 ì´ìžë¥� 지급하지 않으ë©� MSFLì� 무담ë³� 채무ë¡�, Morgan Stanleyê°€ ì „ì•¡ ë³´ì¦í•©ë‹ˆë‹�.

ì§€ê¸� 구조ëŠ� ë‹¨ì¼ ê´€ì°°ì¼(2028ë…� 7ì›� 31ì�)ì—� ê°€ìž� 성과가 저조한 기초ìžì‚°ì—� 기반합니ë‹�:

  • 모든 지수가 최초 수준ì� ìƒíšŒí•˜ë©° ë§ˆê° ì‹� 투ìžìžëŠ” ì›ê¸ˆ + 레버리지 ìƒìй 수ìµì� 받습니다: $1,000 × [1 + (163%â€�173%) × 최저 성과 ì§€ìˆ˜ì˜ ìƒìŠ¹ë¥ ].
  • ì–´ë–¤ 지수ë¼ë� 최초 수준 ì´ìƒì´ê±°ë‚� ê·� 90% ì´ìƒì—서 마ê°í•˜ë©´ ì›ê¸ˆ($1,000)ë§� 반환ë©ë‹ˆë‹�.
  • ì–´ë–¤ 지수가 최초 수준ì� 90% 미만으로 마ê°í•˜ë©´ ìƒí™˜ê¸ˆì€ ì›ê¸ˆ × (성과 계수 + 10%)ì´ë©°, 10% 버í¼ë¥� 초과하는 ì†ì‹¤ì€ 1:1 비율ë¡� ì ìš©ë˜ë©°, 최소 ìƒí™˜ê¸ˆì€ $100 (10%)입니ë‹�.

주요 조건

  • 발행갶Ä: $1,000; ê°€ê²� ì‚°ì • ì‹� ì˜ˆìƒ ê°€ì¹�: ì•� $962.10 (발행, 구조í™� ë°� 헤지 비용 ë°˜ì˜).
  • 레버리지 계수: 2025ë…� 7ì›� 31ì� 행사가/ê°€ê²� ì‚°ì •ì¼ì— 163%â€�173%ë¡� 확정.
  • 버í¼: ê°� ì§€ìˆ˜ì— ëŒ€í•� 10% í•˜ë½ ë³´í˜¸.
  • ë°°í¬: 수수ë£� 기반 ìžë¬¸ 계좌ë¥� 통해 íŒë§¤; 딜러ëŠ� 노트ë‹� 최대 $6.25ì� 구조í™� 수수료를 ë°›ì„ ìˆ� 있으ë©�, MS & Co.ëŠ� íŒë§¤ 수수료를 받지 않ìŒ.
  • 유ë™ì„�: 거래ì†� ìƒìž¥ë˜ì§€ 않ìŒ; 2ì°� ì‹œìž¥ì€ MS & Co.ê°€ 재량으로 ìš´ì˜.
  • CUSIP/ISIN: 61778NCZ2 / US61778NCZ24.

주요 ìœ„í—˜ì€ ë‹¤ìŒê³� 같습니다:

  • Morgan Stanley/MSFLì� ì‹ ìš© 위험 노출; 노트ëŠ� 무담보ì´ë©� 후순위가 아님.
  • 정기 ìˆ˜ìµ ì—†ìŒ; 수ìµì€ 최종 ì§€ìˆ� 성과ì—� ì „ì ìœ¼ë¡œ ì˜ì¡´.
  • 최저 성과 ì§€ìˆ� 집중으로 다ê°í™� 효과 ì—†ìŒ; ë‹¨ì¼ ì§€ìˆ˜ê°€ ë²„í¼ ì´í•˜ë¡� í•˜ë½ ì‹� ì†ì‹¤ ë°œìƒ.
  • 발행가 대ë¹� 시장 ê°€ì¹� í•˜ë½ ê°€ëŠ¥ì„±â€”ë‚´ìž� 비용 ë°� 발행ìžì— 유리í•� ë‚´ë¶€ ìžê¸ˆ 조달 금리 사용 때문.
  • 제한ë� 유ë™ì„�ê³� ë„“ì€ ë§¤ìˆ˜-ë§¤ë„ ìŠ¤í”„ë ˆë“œ 가능성.
  • 세금 처리 불확ì‹�; ì„ ì§€ê¸� 금융 계약으로 예ìƒë˜ë‚˜ IRSê°€ 다르ê²� íŒë‹¨í•� ìˆ� 있ìŒ.

ì� ìƒí’ˆì€ 3ë…� 기간 ë™ì•ˆ ì„� ì§€ìˆ� 모ë‘ì—� 대í•� 강세 ë˜ëŠ” 중립ì � ì „ë§ì� ê°€ì§� 투ìžìž�, ìƒë‹¹í•� í•˜ë½ ìœ„í—˜ì� ê°ìˆ˜í•� ìˆ� 있으ë©� 제한ë� ì£¼ì‹ ìƒìй 참여와 함께 ì ë‹¹í•� 버í¼ë¥� 선호하는 투ìžìžì—ê²� ì í•©í•©ë‹ˆë‹�.

Morgan Stanley Finance LLC propose Buffered PLUS—des notes structurées à capital à risque—échéance 3 août 2028, liées au Dow Jones Industrial Average (INDU), au S&P 500 (SPX) et au Russell 2000 (RTY). Chaque note de 1 000 $ ne verse pas d’intérêts périodiques et constitue une obligation non garantie de MSFL, entièrement garantie par Morgan Stanley.

Mécanisme de remboursement basé sur le sous-jacent le moins performant à la date d’observation unique (31 juillet 2028) :

  • Si tous les indices clôturent au-dessus de leur niveau initial, l’investisseur reçoit le principal + un gain à effet de levier : 1 000 $ × [1 + (163 %â€�173 %) × % de gain du moins performant].
  • Si un indice termine à ou au-dessus de 90 % de son niveau initial, seul le pair (1 000 $) est remboursé.
  • Si un indice clôture en dessous de 90 % de son niveau initial, le remboursement correspond à principal × (facteur de performance + 10 %), avec une perte au-delà de la protection de 10 % au ratio 1:1, et un rachat minimum de 100 $ (10 %).

Principaux termes

  • Prix d’émission : 1 000 $ ; valeur estimée au prix : environ 962,10 $ (intègre les coûts d’émission, de structuration et de couverture).
  • Facteur de levier : fixé entre 163 % et 173 % au 31 juillet 2025, date de strike/pricing.
  • Buffer : protection à la baisse de 10 % sur chaque indice.
  • Distribution : vendu via des comptes de conseil à honoraires ; les distributeurs peuvent percevoir jusqu’Ã� 6,25 $ par note en frais de structuration ; MS & Co. ne percevra pas de commission de vente.
  • Liquidité : non coté en bourse ; le marché secondaire, s’il existe, est assuré uniquement par MS & Co. à sa discrétion.
  • CUSIP/ISIN : 61778NCZ2 / US61778NCZ24.

Risques principaux soulignés par l’émetteur :

  • Exposition au risque de crédit de Morgan Stanley/MSFL ; les notes sont non garanties et non subordonnées.
  • Pas de revenus périodiques ; le rendement dépend uniquement de la performance terminale des indices.
  • Concentration sur l’indice le moins performant annulant la diversification ; une baisse d’un seul indice sous le buffer entraîne des pertes.
  • Valeur de marché probablement inférieure au prix d’émission après lancement, en raison des coûts intégrés et de l’utilisation d’un taux de financement interne avantageux pour l’émetteur.
  • Liquidité limitée et écarts acheteur/vendeur potentiellement larges.
  • Traitement fiscal incertain ; un contrat financier prépayé est attendu, mais l’IRS pourrait ne pas être d’accord.

Le produit s’adresse aux investisseurs ayant une perspective haussière à neutre sur les trois indices sur un horizon de trois ans, capables de tolérer un risque de baisse important et appréciant une protection modérée associée à une participation à effet de levier dans une hausse plafonnée des actions.

Morgan Stanley Finance LLC bietet Buffered PLUS—strukturierten Notes mit Kapitalrisiko—mit Fälligkeit am 3. August 2028, die an den Dow Jones Industrial Average (INDU), S&P 500 (SPX) und Russell 2000 (RTY) gekoppelt sind. Jede $1.000-Note zahlt keine periodischen Zinsen und ist eine ungesicherte Verbindlichkeit von MSFL, vollständig von Morgan Stanley garantiert.

Auszahlungsmechanik basiert auf dem schlechtesten Basiswert am einzigen Beobachtungstag (31. Juli 2028):

  • Schließen alle Indizes über ihrem Anfangsniveau, erhält der Anleger Kapital + gehebelte Aufwärtsrendite: $1.000 × [1 + (163%â€�173%) × % Gewinn des schlechtesten Index].
  • Schließt ein Index auf oder über 90 % seines Anfangswertes, wird nur der Nennwert ($1.000) zurückgezahlt.
  • Schließt ein Index unter 90 % seines Anfangsniveaus, beträgt die Rückzahlung Kapital × (Performancefaktor + 10 %), wobei Verluste über dem 10 %-Puffer im Verhältnis 1:1 getragen werden, mit einer Mindestauszahlung von $100 (10 %).

Wichtige Bedingungen

  • Ausgabepreis: $1.000; geschätzter Wert bei Preisfestsetzung: ca. $962,10 (berücksichtigt Emissions-, Strukturierungs- und Absicherungskosten).
  • Hebelfaktor: wird am 31. Juli 2025, dem Strike-/Preisfestsetzungstag, zwischen 163 % und 173 % festgelegt.
  • Puffer: 10 % Abwärtsschutz pro Index.
  • Vertrieb: Verkauf über gebührenbasierte Beratungskonten; Händler können bis zu $6,25 pro Note als Strukturierungsgebühr erhalten; MS & Co. erhält keine Verkaufsprovision.
  • ³¢¾±±ç³Ü¾±»å¾±³Ùä³Ù: nicht börsennotiert; ein Sekundärmarkt, falls vorhanden, wird ausschließlich von MS & Co. nach eigenem Ermessen bereitgestellt.
  • CUSIP/ISIN: 61778NCZ2 / US61778NCZ24.

Hauptrisiken laut Emittent sind:

  • Exponierung gegenüber dem Kreditrisiko von Morgan Stanley/MSFL; die Notes sind ungesichert und nicht nachrangig.
  • Keine periodischen Erträge; die Rendite hängt ausschließlich von der Endperformance der Indizes ab.
  • Konzentration auf den schlechtesten Index eliminiert Diversifikation; ein einzelner Index unterhalb des Puffers führt zu Verlusten.
  • Marktwert wahrscheinlich unter dem Ausgabepreis nach Emission aufgrund eingebetteter Kosten und Verwendung eines für den Emittenten vorteilhaften internen Finanzierungssatzes.
  • Begrenzte Liquidität und potenziell breite Geld-/Brief-Spreads.
  • Unklare steuerliche Behandlung; Rechtsberatung erwartet einen vorausbezahlten Finanzvertrag, aber das IRS könnte anderer Meinung sein.

Das Produkt richtet sich an Anleger mit bullischer bis neutraler Einschätzung aller drei Indizes über einen Zeitraum von drei Jahren, die erhebliche Abwärtsrisiken tolerieren können und einen moderaten Puffer sowie gehebelte Teilnahme an begrenztem Aktienaufwärtspotenzial schätzen.

Positive
  • Leverage factor of 163%â€�173% amplifies upside if all indices finish above their initial levels.
  • 10% downside buffer shields principal against moderate market declines.
  • Guaranteed minimum redemption of 10% ensures some recovery in worst-case scenarios.
Negative
  • Principal at risk beyond 10% decline; investors can lose up to 90% of capital.
  • Worst-performing index linkage raises likelihood of negative outcome despite gains in other indices.
  • No interest or coupon, resulting in opportunity cost over the three-year term.
  • Estimated value ($962.10) below $1,000 issue price, reflecting embedded fees and internal funding advantage to issuer.
  • Unsecured credit exposure to Morgan Stanley/MSFL may affect repayment and secondary pricing.
  • Not exchange-listed; liquidity dependent on discretionary market-making by MS &Co.
  • Uncertain U.S. tax treatment could adversely affect after-tax returns.

Insights

TL;DR: Three-year note offers 163-173 % upside leverage with 10 % buffer, but embeds fees, credit and worst-of risk.

The Buffered PLUS provides enhanced upside versus direct index investment, yet the structure is heavily skewed against investors once any index falls beyond the 10 % buffer. The preliminary estimated value of $962.10 implies roughly 3.8 % in embedded costs at issuance, and the use of Morgan Stanley’s internal funding rate further depresses investor economics. Because payoff is determined on a single observation date, path dependency is ignored and intraperiod gains can evaporate. Absence of secondary-market listing, combined with the firm’s discretionary market-making, heightens liquidity risk. Overall, the note may suit sophisticated fee-based accounts seeking leveraged equity exposure with limited—but far from complete—downside protection, provided they are comfortable bearing unsecured credit risk.

TL;DR: Product layers issuer credit, market timing and liquidity risks; buffer cushions only first 10 % drop.

The structure converts diversified index exposure into a concentrated worst-of bet, materially increasing the probability of capital loss versus single-index notes. Coupled with a minimum repayment of just 10 % of principal, tail risk is severe (e.g., an 85 % decline causes a 75 % loss). Investors also assume Morgan Stanley senior unsecured credit exposure for three years without coupon compensation. Secondary pricing will likely trail intrinsic value due to bid/ask spreads and credit spread movements. While the 10 % buffer offers limited relief, most severe historical drawdowns in these indices have exceeded that threshold. Consequently, risk-adjusted appeal is modest.

Morgan Stanley Finance LLC propone Buffered PLUS—note strutturate con capitale a rischio—con scadenza al 3 agosto 2028, collegate al Dow Jones Industrial Average (INDU), al S&P 500 (SPX) e al Russell 2000 (RTY). Ogni nota da $1.000 non paga interessi periodici ed è un obbligazione non garantita di MSFL, completamente garantita da Morgan Stanley.

Meccanismo di rimborso basato sul sottostante con la performance peggiore alla data di osservazione unica (31 luglio 2028):

  • Se tutti gli indici chiudono sopra il livello iniziale, l'investitore riceve capitale + rendimento amplificato: $1.000 × [1 + (163%â€�173%) × % di guadagno del peggior indice].
  • Se un indice termina al livello iniziale o sopra il 90% di esso, viene restituito solo il valore nominale ($1.000).
  • Se un indice chiude sotto il 90% del livello iniziale, il rimborso sarà pari a capitale × (fattore di performance + 10%), con una perdita 1:1 oltre il buffer del 10%, con un rimborso minimo di $100 (10%).

Termini principali

  • Prezzo di emissione: $1.000; valore stimato al pricing: circa $962,10 (inclusi costi di emissione, strutturazione e copertura).
  • Fattore di leva: fissato tra 163% e 173% il 31 luglio 2025, data di strike/pricing.
  • Buffer: protezione al ribasso del 10% su ciascun indice.
  • Distribuzione: venduto tramite conti di consulenza a tariffa; i dealer possono ricevere fino a $6,25 per nota come commissione di strutturazione; MS & Co. non riceverà commissioni di vendita.
  • ³¢¾±±ç³Ü¾±»å¾±³Ùà: non quotato in borsa; il mercato secondario, se presente, sarà gestito esclusivamente da MS & Co. a propria discrezione.
  • CUSIP/ISIN: 61778NCZ2 / US61778NCZ24.

Rischi principali evidenziati dall'emittente includono:

  • Esposizione al rischio di credito di Morgan Stanley/MSFL; le note sono non garantite e non subordinate.
  • Nessun reddito periodico; il rendimento dipende esclusivamente dalla performance finale degli indici.
  • Concentrazione sul peggior indice che annulla la diversificazione; un calo di un solo indice sotto il buffer comporta perdite.
  • Valore di mercato probabilmente inferiore al prezzo di emissione dopo il lancio, a causa dei costi incorporati e dell'uso di un tasso di finanziamento interno favorevole all'emittente.
  • Liquidità limitata e possibili ampi spread denaro-lettera.
  • Trattamento fiscale incerto; si prevede un contratto finanziario prepagato, ma l'IRS potrebbe avere un'opinione diversa.

Il prodotto è rivolto a investitori con un outlook rialzista o neutrale sui tre indici in un orizzonte triennale, che possono tollerare rischi significativi al ribasso e apprezzano un buffer moderato insieme a una partecipazione leva con upside azionario limitato.

Morgan Stanley Finance LLC ofrece Buffered PLUS—notas estructuradas con principal en riesgo—con vencimiento el 3 de agosto de 2028, vinculadas al Dow Jones Industrial Average (INDU), S&P 500 (SPX) y Russell 2000 (RTY). Cada nota de $1,000 no paga intereses periódicos y es una obligación no garantizada de MSFL, totalmente respaldada por Morgan Stanley.

Mecánica de pago basada en el activo subyacente con peor desempeño en la única fecha de observación (31 de julio de 2028):

  • Si todos los índices cierran por encima de su nivel inicial, el inversor recibe principal + ganancia apalancada: $1,000 × [1 + (163%â€�173%) × % de ganancia del peor índice].
  • Si algún índice termina en o por encima del 90% de su nivel inicial, solo se devuelve el valor nominal ($1,000).
  • Si algún índice cierra por debajo del 90% de su nivel inicial, el reembolso será principal × (factor de rendimiento + 10%), con una pérdida 1:1 más allá del buffer del 10%, con un reembolso mínimo de $100 (10%).

Términos clave

  • Precio de emisión: $1,000; valor estimado en precio: aproximadamente $962.10 (incluye costos de emisión, estructuración y cobertura).
  • Factor de apalancamiento: fijado entre 163% y 173% el 31 de julio de 2025, fecha de strike/precio.
  • Buffer: protección a la baja del 10% en cada índice.
  • ¶Ù¾±²õ³Ù°ù¾±²ú³Ü³¦¾±Ã³²Ô: vendido a través de cuentas de asesoría con tarifa; los distribuidores pueden ganar hasta $6.25 por nota como comisión de estructuración; MS & Co. no recibirá comisión de venta.
  • Liquidez: no cotizado en bolsa; el mercado secundario, si existe, será realizado únicamente por MS & Co. a su discreción.
  • CUSIP/ISIN: 61778NCZ2 / US61778NCZ24.

Riesgos principales señalados por el emisor incluyen:

  • Exposición al riesgo crediticio de Morgan Stanley/MSFL; las notas son no garantizadas y no subordinadas.
  • No hay ingresos periódicos; el retorno depende únicamente del desempeño final de los índices.
  • Concentración en el índice de peor desempeño que elimina la diversificación; una caída de un solo índice bajo el buffer provoca pérdidas.
  • Valor de mercado probablemente inferior al precio de emisión tras el lanzamiento debido a costos incorporados y uso de una tasa interna de financiamiento favorable para el emisor.
  • Liquidez limitada y posibles amplios spreads entre oferta y demanda.
  • Tratamiento fiscal incierto; se espera un contrato financiero prepagado, pero el IRS podría no estar de acuerdo.

El producto está dirigido a inversores con una perspectiva alcista a neutral en los tres índices en un horizonte de tres años, que pueden tolerar riesgos significativos a la baja y valoran un buffer moderado junto con participación apalancada en una subida limitada del mercado accionario.

Morgan Stanley Finance LLCëŠ� 2028ë…� 8ì›� 3ì� 만기ì� Buffered PLUS—ì›ê¸� 위험 구조í™� ì¦ê¶Œì� 제공하며, Dow Jones Industrial Average (INDU), S&P 500 (SPX), Russell 2000 (RTY) ì§€ìˆ˜ì— ì—°ë™ë©ë‹ˆë‹�. ê°� $1,000 노트ëŠ� 정기 ì´ìžë¥� 지급하지 않으ë©� MSFLì� 무담ë³� 채무ë¡�, Morgan Stanleyê°€ ì „ì•¡ ë³´ì¦í•©ë‹ˆë‹�.

ì§€ê¸� 구조ëŠ� ë‹¨ì¼ ê´€ì°°ì¼(2028ë…� 7ì›� 31ì�)ì—� ê°€ìž� 성과가 저조한 기초ìžì‚°ì—� 기반합니ë‹�:

  • 모든 지수가 최초 수준ì� ìƒíšŒí•˜ë©° ë§ˆê° ì‹� 투ìžìžëŠ” ì›ê¸ˆ + 레버리지 ìƒìй 수ìµì� 받습니다: $1,000 × [1 + (163%â€�173%) × 최저 성과 ì§€ìˆ˜ì˜ ìƒìŠ¹ë¥ ].
  • ì–´ë–¤ 지수ë¼ë� 최초 수준 ì´ìƒì´ê±°ë‚� ê·� 90% ì´ìƒì—서 마ê°í•˜ë©´ ì›ê¸ˆ($1,000)ë§� 반환ë©ë‹ˆë‹�.
  • ì–´ë–¤ 지수가 최초 수준ì� 90% 미만으로 마ê°í•˜ë©´ ìƒí™˜ê¸ˆì€ ì›ê¸ˆ × (성과 계수 + 10%)ì´ë©°, 10% 버í¼ë¥� 초과하는 ì†ì‹¤ì€ 1:1 비율ë¡� ì ìš©ë˜ë©°, 최소 ìƒí™˜ê¸ˆì€ $100 (10%)입니ë‹�.

주요 조건

  • 발행갶Ä: $1,000; ê°€ê²� ì‚°ì • ì‹� ì˜ˆìƒ ê°€ì¹�: ì•� $962.10 (발행, 구조í™� ë°� 헤지 비용 ë°˜ì˜).
  • 레버리지 계수: 2025ë…� 7ì›� 31ì� 행사가/ê°€ê²� ì‚°ì •ì¼ì— 163%â€�173%ë¡� 확정.
  • 버í¼: ê°� ì§€ìˆ˜ì— ëŒ€í•� 10% í•˜ë½ ë³´í˜¸.
  • ë°°í¬: 수수ë£� 기반 ìžë¬¸ 계좌ë¥� 통해 íŒë§¤; 딜러ëŠ� 노트ë‹� 최대 $6.25ì� 구조í™� 수수료를 ë°›ì„ ìˆ� 있으ë©�, MS & Co.ëŠ� íŒë§¤ 수수료를 받지 않ìŒ.
  • 유ë™ì„�: 거래ì†� ìƒìž¥ë˜ì§€ 않ìŒ; 2ì°� ì‹œìž¥ì€ MS & Co.ê°€ 재량으로 ìš´ì˜.
  • CUSIP/ISIN: 61778NCZ2 / US61778NCZ24.

주요 ìœ„í—˜ì€ ë‹¤ìŒê³� 같습니다:

  • Morgan Stanley/MSFLì� ì‹ ìš© 위험 노출; 노트ëŠ� 무담보ì´ë©� 후순위가 아님.
  • 정기 ìˆ˜ìµ ì—†ìŒ; 수ìµì€ 최종 ì§€ìˆ� 성과ì—� ì „ì ìœ¼ë¡œ ì˜ì¡´.
  • 최저 성과 ì§€ìˆ� 집중으로 다ê°í™� 효과 ì—†ìŒ; ë‹¨ì¼ ì§€ìˆ˜ê°€ ë²„í¼ ì´í•˜ë¡� í•˜ë½ ì‹� ì†ì‹¤ ë°œìƒ.
  • 발행가 대ë¹� 시장 ê°€ì¹� í•˜ë½ ê°€ëŠ¥ì„±â€”ë‚´ìž� 비용 ë°� 발행ìžì— 유리í•� ë‚´ë¶€ ìžê¸ˆ 조달 금리 사용 때문.
  • 제한ë� 유ë™ì„�ê³� ë„“ì€ ë§¤ìˆ˜-ë§¤ë„ ìŠ¤í”„ë ˆë“œ 가능성.
  • 세금 처리 불확ì‹�; ì„ ì§€ê¸� 금융 계약으로 예ìƒë˜ë‚˜ IRSê°€ 다르ê²� íŒë‹¨í•� ìˆ� 있ìŒ.

ì� ìƒí’ˆì€ 3ë…� 기간 ë™ì•ˆ ì„� ì§€ìˆ� 모ë‘ì—� 대í•� 강세 ë˜ëŠ” 중립ì � ì „ë§ì� ê°€ì§� 투ìžìž�, ìƒë‹¹í•� í•˜ë½ ìœ„í—˜ì� ê°ìˆ˜í•� ìˆ� 있으ë©� 제한ë� ì£¼ì‹ ìƒìй 참여와 함께 ì ë‹¹í•� 버í¼ë¥� 선호하는 투ìžìžì—ê²� ì í•©í•©ë‹ˆë‹�.

Morgan Stanley Finance LLC propose Buffered PLUS—des notes structurées à capital à risque—échéance 3 août 2028, liées au Dow Jones Industrial Average (INDU), au S&P 500 (SPX) et au Russell 2000 (RTY). Chaque note de 1 000 $ ne verse pas d’intérêts périodiques et constitue une obligation non garantie de MSFL, entièrement garantie par Morgan Stanley.

Mécanisme de remboursement basé sur le sous-jacent le moins performant à la date d’observation unique (31 juillet 2028) :

  • Si tous les indices clôturent au-dessus de leur niveau initial, l’investisseur reçoit le principal + un gain à effet de levier : 1 000 $ × [1 + (163 %â€�173 %) × % de gain du moins performant].
  • Si un indice termine à ou au-dessus de 90 % de son niveau initial, seul le pair (1 000 $) est remboursé.
  • Si un indice clôture en dessous de 90 % de son niveau initial, le remboursement correspond à principal × (facteur de performance + 10 %), avec une perte au-delà de la protection de 10 % au ratio 1:1, et un rachat minimum de 100 $ (10 %).

Principaux termes

  • Prix d’émission : 1 000 $ ; valeur estimée au prix : environ 962,10 $ (intègre les coûts d’émission, de structuration et de couverture).
  • Facteur de levier : fixé entre 163 % et 173 % au 31 juillet 2025, date de strike/pricing.
  • Buffer : protection à la baisse de 10 % sur chaque indice.
  • Distribution : vendu via des comptes de conseil à honoraires ; les distributeurs peuvent percevoir jusqu’Ã� 6,25 $ par note en frais de structuration ; MS & Co. ne percevra pas de commission de vente.
  • Liquidité : non coté en bourse ; le marché secondaire, s’il existe, est assuré uniquement par MS & Co. à sa discrétion.
  • CUSIP/ISIN : 61778NCZ2 / US61778NCZ24.

Risques principaux soulignés par l’émetteur :

  • Exposition au risque de crédit de Morgan Stanley/MSFL ; les notes sont non garanties et non subordonnées.
  • Pas de revenus périodiques ; le rendement dépend uniquement de la performance terminale des indices.
  • Concentration sur l’indice le moins performant annulant la diversification ; une baisse d’un seul indice sous le buffer entraîne des pertes.
  • Valeur de marché probablement inférieure au prix d’émission après lancement, en raison des coûts intégrés et de l’utilisation d’un taux de financement interne avantageux pour l’émetteur.
  • Liquidité limitée et écarts acheteur/vendeur potentiellement larges.
  • Traitement fiscal incertain ; un contrat financier prépayé est attendu, mais l’IRS pourrait ne pas être d’accord.

Le produit s’adresse aux investisseurs ayant une perspective haussière à neutre sur les trois indices sur un horizon de trois ans, capables de tolérer un risque de baisse important et appréciant une protection modérée associée à une participation à effet de levier dans une hausse plafonnée des actions.

Morgan Stanley Finance LLC bietet Buffered PLUS—strukturierten Notes mit Kapitalrisiko—mit Fälligkeit am 3. August 2028, die an den Dow Jones Industrial Average (INDU), S&P 500 (SPX) und Russell 2000 (RTY) gekoppelt sind. Jede $1.000-Note zahlt keine periodischen Zinsen und ist eine ungesicherte Verbindlichkeit von MSFL, vollständig von Morgan Stanley garantiert.

Auszahlungsmechanik basiert auf dem schlechtesten Basiswert am einzigen Beobachtungstag (31. Juli 2028):

  • Schließen alle Indizes über ihrem Anfangsniveau, erhält der Anleger Kapital + gehebelte Aufwärtsrendite: $1.000 × [1 + (163%â€�173%) × % Gewinn des schlechtesten Index].
  • Schließt ein Index auf oder über 90 % seines Anfangswertes, wird nur der Nennwert ($1.000) zurückgezahlt.
  • Schließt ein Index unter 90 % seines Anfangsniveaus, beträgt die Rückzahlung Kapital × (Performancefaktor + 10 %), wobei Verluste über dem 10 %-Puffer im Verhältnis 1:1 getragen werden, mit einer Mindestauszahlung von $100 (10 %).

Wichtige Bedingungen

  • Ausgabepreis: $1.000; geschätzter Wert bei Preisfestsetzung: ca. $962,10 (berücksichtigt Emissions-, Strukturierungs- und Absicherungskosten).
  • Hebelfaktor: wird am 31. Juli 2025, dem Strike-/Preisfestsetzungstag, zwischen 163 % und 173 % festgelegt.
  • Puffer: 10 % Abwärtsschutz pro Index.
  • Vertrieb: Verkauf über gebührenbasierte Beratungskonten; Händler können bis zu $6,25 pro Note als Strukturierungsgebühr erhalten; MS & Co. erhält keine Verkaufsprovision.
  • ³¢¾±±ç³Ü¾±»å¾±³Ùä³Ù: nicht börsennotiert; ein Sekundärmarkt, falls vorhanden, wird ausschließlich von MS & Co. nach eigenem Ermessen bereitgestellt.
  • CUSIP/ISIN: 61778NCZ2 / US61778NCZ24.

Hauptrisiken laut Emittent sind:

  • Exponierung gegenüber dem Kreditrisiko von Morgan Stanley/MSFL; die Notes sind ungesichert und nicht nachrangig.
  • Keine periodischen Erträge; die Rendite hängt ausschließlich von der Endperformance der Indizes ab.
  • Konzentration auf den schlechtesten Index eliminiert Diversifikation; ein einzelner Index unterhalb des Puffers führt zu Verlusten.
  • Marktwert wahrscheinlich unter dem Ausgabepreis nach Emission aufgrund eingebetteter Kosten und Verwendung eines für den Emittenten vorteilhaften internen Finanzierungssatzes.
  • Begrenzte Liquidität und potenziell breite Geld-/Brief-Spreads.
  • Unklare steuerliche Behandlung; Rechtsberatung erwartet einen vorausbezahlten Finanzvertrag, aber das IRS könnte anderer Meinung sein.

Das Produkt richtet sich an Anleger mit bullischer bis neutraler Einschätzung aller drei Indizes über einen Zeitraum von drei Jahren, die erhebliche Abwärtsrisiken tolerieren können und einen moderaten Puffer sowie gehebelte Teilnahme an begrenztem Aktienaufwärtspotenzial schätzen.

Preliminary Pricing Supplement No. 9,110

Registration Statement Nos. 333-275587; 333-275587-01

Dated July 1, 2025

Filed pursuant to Rule 424(b)(2)

Morgan Stanley Finance LLC

Structured Investments

Buffered PLUS due August 3, 2028

Based on the Worst Performing of the Dow Jones Industrial AverageSM, the S&P 500® Index and the Russell 2000® Index

Buffered Performance Leveraged Upside SecuritiesSM

Fully and Unconditionally Guaranteed by Morgan Stanley

Principal at Risk Securities

The Buffered PLUS (the “securities”) are unsecured obligations of Morgan Stanley Finance LLC (“MSFL”) and are fully and unconditionally guaranteed by Morgan Stanley. The securities will pay no interest and have the terms described in the accompanying product supplement, index supplement and prospectus, as supplemented or modified by this document.

Payment at maturity. At maturity, if the final level of each underlier is greater than its initial level, investors will receive the stated principal amount plus the leveraged upside payment. If the final level of any underlier is equal to or less than its initial level but the final level of each underlier is greater than or equal to its buffer level, investors will receive only the stated principal amount at maturity. If, however, the final level of any underlier is less than its buffer level, investors will lose 1% for every 1% decline in the level of the worst performing underlier beyond the specified buffer amount. Under these circumstances, the payment at maturity will be less, and may be significantly less, than the stated principal amount of the securities, subject to the minimum payment at maturity.

The value of the securities is based on the worst performing underlier. The fact that the securities are linked to more than one underlier does not provide any asset diversification benefits and instead means that a decline in the level of any underlier beyond its buffer level will adversely affect your return on the securities, even if the other underliers have appreciated or have not declined as much.

The securities are for investors who seek a return based on the performance of the worst performing underlier and who are willing to risk their principal and forgo current income in exchange for the upside leverage feature and the buffer feature that applies to any negative performance of the worst performing underlier over the term of the securities. Investors in the securities must be willing to accept the risk of losing a significant portion of their initial investment based on the performance of any underlier. The securities are notes issued as part of MSFL’s Series A Global Medium-Term Notes program.

All payments are subject to our credit risk. If we default on our obligations, you could lose some or all of your investment. These securities are not secured obligations and you will not have any security interest in, or otherwise have any access to, any underlying reference asset or assets.

TERMS

Issuer:

Morgan Stanley Finance LLC

Guarantor:

Morgan Stanley

Stated principal amount:

$1,000 per security

Issue price:

$1,000 per security (see “Commissions and issue price” below) 

Aggregate principal amount:

$

Underliers:

Dow Jones Industrial AverageSM (the “INDU Index”), S&P 500® Index (the “SPX Index”) and Russell 2000® Index (the “RTY Index”). We refer to each of the INDU Index, the SPX Index and the RTY Index as an underlying index.

Strike date:

July 31, 2025

Pricing date:

July 31, 2025

Original issue date:

August 5, 2025

Observation date:

July 31, 2028, subject to postponement for non-trading days and certain market disruption events

Maturity date:

August 3, 2028

 

Terms continued on the following page

Agent:

Morgan Stanley & Co. LLC (“MS & Co.”), an affiliate of MSFL and a wholly owned subsidiary of Morgan Stanley. See “Supplemental information regarding plan of distribution; conflicts of interest.”

Estimated value on the pricing date:

Approximately $962.10 per security, or within $45.00 of that estimate. See “Estimated Value of the Securities” on page 3.

Commissions and issue price:

Price to public

Agent’s commissions and fees(1)(2)

Proceeds to us(3)

Per security

$1,000

$

$

Total

$

$

$

(1)The securities will be sold only to investors purchasing the securities in fee-based advisory accounts.

(2)MS & Co. expects to sell all of the securities that it purchases from us to an unaffiliated dealer at a price of $ per security, for further sale to certain fee-based advisory accounts at the price to public of $1,000 per security. In addition, selected dealers and their financial advisors may receive a structuring fee of up to $6.25 for each security from the agent or its affiliates. MS & Co. will not receive a sales commission with respect to the securities. See “Supplemental information regarding plan of distribution; conflicts of interest.” For additional information, see “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement.

(3)See “Use of Proceeds and Hedging” in the accompanying product supplement.

The securities involve risks not associated with an investment in ordinary debt securities. See “Risk Factors” beginning on page 5.

The Securities and Exchange Commission and state securities regulators have not approved or disapproved these securities, or determined if this document or the accompanying product supplement, index supplement and prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The securities are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.

You should read this document together with the related product supplement, index supplement and prospectus, each of which can be accessed via the hyperlinks below. When you read the accompanying index supplement, please note that all references in such supplement to the prospectus dated November 16, 2023, or to any sections therein, should refer instead to the accompanying prospectus dated April 12, 2024 or to the corresponding sections of such prospectus, as applicable. Please also see “Additional Terms of the Securities” and “Additional Information About the Securities” at the end of this document.

References to “we,” “us” and “our” refer to Morgan Stanley or MSFL, or Morgan Stanley and MSFL collectively, as the context requires.

Product Supplement for Principal at Risk Securities dated February 7, 2025 Index Supplement dated November 16, 2023 Prospectus dated April 12, 2024

 

Morgan Stanley Finance LLC

Buffered PLUS

Principal at Risk Securities

 

Terms continued from the previous page

Payment at maturity per security:

If the final level of each underlier is greater than its initial level:

stated principal amount + leveraged upside payment

If the final level of any underlier is equal to or less than its initial level but the final level of each underlier is greater than or equal to its buffer level:

stated principal amount

If the final level of any underlier is less than its buffer level:

stated principal amount × (performance factor of the worst performing underlier + buffer amount)

Under these circumstances, the payment at maturity will be less, and may be significantly less, than the stated principal amount, subject to the minimum payment at maturity.

Final level:

With respect to each underlier, the closing level on the observation date

Initial level:

With respect to the INDU Index, , which is its closing level on the strike date

With respect to the SPX Index, , which is its closing level on the strike date

With respect to the RTY Index, , which is its closing level on the strike date

Leveraged upside payment:

stated principal amount × leverage factor × underlier percent change of the worst performing underlier

Leverage factor:

163% to 173%. The actual leverage factor will be determined on the pricing date.

Underlier percent change:

With respect to each underlier, (final level – initial level) / initial level

Buffer level:

With respect to the INDU Index, , which is 90% of its initial level

With respect to the SPX Index, , which is 90% of its initial level

With respect to the RTY Index, , which is 90% of its initial level

Worst performing underlier:

The underlier with the lowest percentage return from its initial level to its final level

Performance factor:

With respect to each underlier, final level / initial level

Buffer amount:

10%

Minimum payment at maturity:

10% of the stated principal amount

CUSIP:

61778NCZ2

ISIN:

US61778NCZ24

Listing:

The securities will not be listed on any securities exchange.

 Page 2

Morgan Stanley Finance LLC

Buffered PLUS

Principal at Risk Securities

 

Estimated Value of the Securities

The original issue price of each security is $1,000. This price includes costs associated with issuing, selling, structuring and hedging the securities, which are borne by you, and, consequently, the estimated value of the securities on the pricing date will be less than $1,000. Our estimate of the value of the securities as determined on the pricing date will be within the range specified on the cover hereof and will be set forth on the cover of the final pricing supplement.

What goes into the estimated value on the pricing date?

In valuing the securities on the pricing date, we take into account that the securities comprise both a debt component and a performance-based component linked to the underliers. The estimated value of the securities is determined using our own pricing and valuation models, market inputs and assumptions relating to the underliers, instruments based on the underliers, volatility and other factors including current and expected interest rates, as well as an interest rate related to our secondary market credit spread, which is the implied interest rate at which our conventional fixed rate debt trades in the secondary market.

What determines the economic terms of the securities?

In determining the economic terms of the securities, we use an internal funding rate, which is likely to be lower than our secondary market credit spreads and therefore advantageous to us. If the issuing, selling, structuring and hedging costs borne by you were lower or if the internal funding rate were higher, one or more of the economic terms of the securities would be more favorable to you.

What is the relationship between the estimated value on the pricing date and the secondary market price of the securities?

The price at which MS & Co. purchases the securities in the secondary market, absent changes in market conditions, including those related to the underliers, may vary from, and be lower than, the estimated value on the pricing date, because the secondary market price takes into account our secondary market credit spread as well as the bid-offer spread that MS & Co. would charge in a secondary market transaction of this type and other factors. However, because the costs associated with issuing, selling, structuring and hedging the securities are not fully deducted upon issuance, to the extent that MS & Co. may buy or sell the securities in the secondary market during the amortization period specified herein, absent changes in market conditions, including those related to the underliers, and to our secondary market credit spreads, it would do so based on values higher than the estimated value. We expect that those higher values will also be reflected in your brokerage account statements.

MS & Co. may, but is not obligated to, make a market in the securities, and, if it once chooses to make a market, may cease doing so at any time.

 Page 3

Morgan Stanley Finance LLC

Buffered PLUS

Principal at Risk Securities

 

Hypothetical Examples

Hypothetical Payoff Diagram 

The payment at maturity will be based solely on the performance of the worst performing underlier, which could be any underlier. The payoff diagram below illustrates the payment at maturity for a range of hypothetical performances of the worst performing underlier over the term of the securities, based on the following terms:

Stated principal amount:

$1,000 per security

Hypothetical leverage factor:

163%

Buffer level:

90% of the initial level

Buffer amount:

10%

Minimum payment at maturity:

10% of the stated principal amount

Hypothetical Payoff Diagram

 

Upside Scenario. If the final level of the worst performing underlier is greater than its initial level, investors will receive the stated principal amount plus 163% of the appreciation of the worst performing underlier over the term of the securities.

oIf the worst performing underlier appreciates 10%, investors will receive $1,163‬ per security, or 116.30% of the stated principal amount.

Par Scenario. If the final level of the worst performing underlier is equal to or less than its initial level but is greater than or equal to its buffer level, investors will receive the stated principal amount.

oIf the worst performing underlier depreciates 5%, investors will receive $1,000 per security.

Downside Scenario. If the final level of the worst performing underlier is less than its buffer level, investors will receive an amount that is less, and may be significantly less, than the stated principal amount, based on a 1% loss of principal for each 1% decline in the level of the worst performing underlier beyond the buffer amount.

oIf the worst performing underlier depreciates 85%, investors will lose 75% of their principal and receive only $250 per security at maturity, or 25% of the stated principal amount.

 Page 4

Morgan Stanley Finance LLC

Buffered PLUS

Principal at Risk Securities

 

Risk Factors

This section describes the material risks relating to the securities. For further discussion of these and other risks, you should read the section entitled “Risk Factors” in the accompanying product supplement and prospectus. We also urge you to consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the securities.

Risks Relating to an Investment in the Securities

The securities provide for only the minimum payment at maturity and do not pay interest. The terms of the securities differ from those of ordinary debt securities in that they provide for only the minimum payment at maturity and do not pay interest. If the final level of any underlier is less than its buffer level, the payout at maturity will be an amount in cash that is less than the stated principal amount of each security, and you will lose an amount proportionate to the full decline in the level of the worst performing underlier over the term of the securities beyond the buffer amount. You could lose a significant portion of your initial investment in the securities.

The amount payable on the securities is not linked to the values of the underliers at any time other than the observation date. The final levels will be based on the closing levels of the underliers on the observation date, subject to postponement for non-trading days and certain market disruption events. Even if the value of each underlier appreciates prior to the observation date but then the value of any underlier drops by the observation date, the payment at maturity may be less, and may be significantly less, than it would have been had the payment at maturity been linked to the values of the underliers prior to such drop. Although the actual values of the underliers on the stated maturity date or at other times during the term of the securities may be higher than their respective closing levels on the observation date, the payment at maturity will be based solely on the closing levels of the underliers on the observation date.

The market price of the securities may be influenced by many unpredictable factors. Several factors, many of which are beyond our control, will influence the value of the securities in the secondary market and the price at which MS & Co. may be willing to purchase or sell the securities in the secondary market. We expect that generally the value of each underlier at any time will affect the value of the securities more than any other single factor. Other factors that may influence the value of the securities include:

othe volatility (frequency and magnitude of changes in value) of the underliers;

ointerest and yield rates in the market;

othe level of correlation between the underliers;

ogeopolitical conditions and economic, financial, political, regulatory or judicial events that affect the underliers or equity markets generally;

othe availability of comparable instruments;

othe composition of each underlier and changes in the component securities of each underlier;

othe time remaining until the securities mature; and

oany actual or anticipated changes in our credit ratings or credit spreads.

Some or all of these factors will influence the price that you will receive if you sell your securities prior to maturity. Generally, the longer the time remaining to maturity, the more the market price of the securities will be affected by the other factors described above. For example, you may have to sell your securities at a substantial discount from the stated principal amount if, at the time of sale, the closing level of any underlier is at, below or not sufficiently above its buffer level, or if market interest rates rise.

You can review the historical closing levels of the underliers in the section of this document called “Historical Information.” You cannot predict the future performance of an underlier based on its historical performance. The values of the underliers may be, and have recently been, volatile, and we can give you no assurance that the volatility will lessen. There can be no assurance that the final level of each underlier will be greater than or equal to its buffer level so that you do not suffer a loss on your initial investment in the securities.

The securities are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities. You are dependent on our ability to pay all amounts due on the securities, and, therefore, you are subject to our credit risk. The securities are not guaranteed by any other entity. If we default on our obligations under the securities, your investment would be at risk and you could lose some or all of your investment. As a result, the market value of the securities prior to maturity will be affected by changes in the market’s view of our creditworthiness. Any actual or anticipated decline in our credit ratings or increase in the credit spreads charged by the market for taking our credit risk is likely to adversely affect the market value of the securities.

As a finance subsidiary, MSFL has no independent operations and will have no independent assets. As a finance subsidiary, MSFL has no independent operations beyond the issuance and administration of its securities and will have no independent assets available for distributions to holders of MSFL securities if they make claims in respect of such securities in a

 Page 5

Morgan Stanley Finance LLC

Buffered PLUS

Principal at Risk Securities

 

bankruptcy, resolution or similar proceeding. Accordingly, any recoveries by such holders will be limited to those available under the related guarantee by Morgan Stanley and that guarantee will rank pari passu with all other unsecured, unsubordinated obligations of Morgan Stanley. Holders will have recourse only to a single claim against Morgan Stanley and its assets under the guarantee. Holders of securities issued by MSFL should accordingly assume that in any such proceedings they would not have any priority over and should be treated pari passu with the claims of other unsecured, unsubordinated creditors of Morgan Stanley, including holders of Morgan Stanley-issued securities.

The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the securities in the original issue price reduce the economic terms of the securities, cause the estimated value of the securities to be less than the original issue price and will adversely affect secondary market prices. Assuming no change in market conditions or any other relevant factors, the prices, if any, at which dealers, including MS & Co., may be willing to purchase the securities in secondary market transactions will likely be significantly lower than the original issue price, because secondary market prices will exclude the issuing, selling, structuring and hedging-related costs that are included in the original issue price and borne by you and because the secondary market prices will reflect our secondary market credit spreads and the bid-offer spread that any dealer would charge in a secondary market transaction of this type as well as other factors.

The inclusion of the costs of issuing, selling, structuring and hedging the securities in the original issue price and the lower rate we are willing to pay as issuer make the economic terms of the securities less favorable to you than they otherwise would be.

However, because the costs associated with issuing, selling, structuring and hedging the securities are not fully deducted upon issuance, to the extent that MS & Co. may buy or sell the securities in the secondary market during the amortization period specified herein, absent changes in market conditions, including those related to the underliers, and to our secondary market credit spreads, it would do so based on values higher than the estimated value, and we expect that those higher values will also be reflected in your brokerage account statements.

The estimated value of the securities is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price. These pricing and valuation models are proprietary and rely in part on subjective views of certain market inputs and certain assumptions about future events, which may prove to be incorrect. As a result, because there is no market-standard way to value these types of securities, our models may yield a higher estimated value of the securities than those generated by others, including other dealers in the market, if they attempted to value the securities. In addition, the estimated value on the pricing date does not represent a minimum or maximum price at which dealers, including MS & Co., would be willing to purchase your securities in the secondary market (if any exists) at any time. The value of your securities at any time after the date of this document will vary based on many factors that cannot be predicted with accuracy, including our creditworthiness and changes in market conditions. See also “The market price of the securities may be influenced by many unpredictable factors” above.

The securities will not be listed on any securities exchange and secondary trading may be limited. The securities will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. MS & Co. may, but is not obligated to, make a market in the securities and, if it once chooses to make a market, may cease doing so at any time. When it does make a market, it will generally do so for transactions of routine secondary market size at prices based on its estimate of the current value of the securities, taking into account its bid/offer spread, our credit spreads, market volatility, the notional size of the proposed sale, the cost of unwinding any related hedging positions, the time remaining to maturity and the likelihood that it will be able to resell the securities. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the securities easily. Since other broker-dealers may not participate significantly in the secondary market for the securities, the price at which you may be able to trade your securities is likely to depend on the price, if any, at which MS & Co. is willing to transact. If, at any time, MS & Co. were to cease making a market in the securities, it is likely that there would be no secondary market for the securities. Accordingly, you should be willing to hold your securities to maturity.

As discussed in more detail in the accompanying product supplement, investing in the securities is not equivalent to investing in the underlier(s).

The U.S. federal income tax consequences of an investment in the securities are uncertain. There is no direct legal authority regarding the proper U.S. federal income tax treatment of the securities, and significant aspects of the tax treatment of the securities are uncertain. You should review carefully the section entitled “United States Federal Income Tax Considerations” herein, in combination with the section entitled “United States Federal Income Tax Considerations” in the accompanying product supplement, and consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities.

Risks Relating to the Underlier(s)

Because your return on the securities will depend upon the performance of the underlier(s), the securities are subject to the following risk(s), as discussed in more detail in the accompanying product supplement.

oYou are exposed to the price risk of each underlier.

 Page 6

Morgan Stanley Finance LLC

Buffered PLUS

Principal at Risk Securities

 

oBecause the securities are linked to the performance of the worst performing underlier, you are exposed to a greater risk of not receiving a positive return on the securities and/or sustaining a loss on your investment than if the securities were linked to just one underlier.

oAdjustments to an underlying index could adversely affect the value of the securities.

The securities are subject to risks associated with small-capitalization companies. The Russell 2000® Index consists of stocks issued by companies with relatively small market capitalization. These companies often have greater stock price volatility, lower trading volume and less liquidity than large-capitalization companies and therefore the Russell 2000® Index may be more volatile than indices that consist of stocks issued by large-capitalization companies. Stock prices of small-capitalization companies are also more vulnerable than those of large-capitalization companies to adverse business and economic developments, and the stocks of small-capitalization companies may be thinly traded. In addition, small capitalization companies are typically less well-established and less stable financially than large-capitalization companies and may depend on a small number of key personnel, making them more vulnerable to loss of personnel. Such companies tend to have smaller revenues, less diverse product lines, smaller shares of their product or service markets, fewer financial resources and less competitive strengths than large-capitalization companies and are more susceptible to adverse developments related to their products.

Risks Relating to Conflicts of Interest

In engaging in certain activities described below and as discussed in more detail in the accompanying product supplement, our affiliates may take actions that may adversely affect the value of and your return on the securities, and in so doing they will have no obligation to consider your interests as an investor in the securities.

The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities. As calculation agent, MS & Co. will make any determinations necessary to calculate any payment(s) on the securities. Moreover, certain determinations made by MS & Co., in its capacity as calculation agent, may require it to exercise discretion and make subjective judgments, which may adversely affect your return on the securities. In addition, MS & Co. has determined the estimated value of the securities on the pricing date.

Hedging and trading activity by our affiliates could potentially adversely affect the value of the securities.

 Page 7

Morgan Stanley Finance LLC

Buffered PLUS

Principal at Risk Securities

 

Historical Information

Dow Jones Industrial AverageSM Overview

Bloomberg Ticker Symbol: INDU

The Dow Jones Industrial AverageSM is a price-weighted index composed of 30 common stocks selected as representative of the broad market of U.S. industry, excluding transportation and utilities. The underlying index publisher with respect to the Dow Jones Industrial AverageSM is S&P® Dow Jones Indices LLC, or any successor thereof. For additional information about the Dow Jones Industrial AverageSM, see the information set forth under “Dow Jones Industrial AverageSM” in the accompanying index supplement.

The closing level of the INDU Index on June 24, 2025 was 43,089.02. The following graph sets forth the daily closing levels of the underlier for the period noted below. We obtained the historical information presented in this document from Bloomberg Financial Markets, without independent verification. The underlier has at times experienced periods of high volatility. You should not take the historical closing levels of the underlier as an indication of its future performance, and no assurance can be given as to the closing level of the underlier at any time.

INDU Index Daily Closing Levels

January 1, 2020 to June 24, 2025

 Page 8

Morgan Stanley Finance LLC

Buffered PLUS

Principal at Risk Securities

 

S&P 500® Index Overview

Bloomberg Ticker Symbol: SPX

The S&P 500® Index is intended to provide a benchmark for performance measurement of the large capitalization segment of the U.S. equity markets by tracking the stock price movement of 500 companies with large market capitalizations. The underlying index publisher with respect to the S&P 500® Index is S&P® Dow Jones Indices LLC, or any successor thereof. Component stocks of the S&P 500® Index are required to have a total company level market capitalization that reflects approximately the 85th percentile of the S&P® Total Market Index. The S&P 500® Index measures the relative performance of the common stocks of 500 companies as of a particular time as compared to the performance of the common stocks of 500 similar companies during the base period of the years 1941 through 1943. For additional information about the S&P 500® Index, see the information set forth under “S&P® U.S. Indices—S&P 500® Index” in the accompanying index supplement.

The closing level of the SPX Index on June 24, 2025 was 6,092.18. The following graph sets forth the daily closing levels of the underlier for the period noted below. We obtained the historical information presented in this document from Bloomberg Financial Markets, without independent verification. The underlier has at times experienced periods of high volatility. You should not take the historical closing levels of the underlier as an indication of its future performance, and no assurance can be given as to the closing level of the underlier at any time.

SPX Index Daily Closing Levels

January 1, 2020 to June 24, 2025

 Page 9

Morgan Stanley Finance LLC

Buffered PLUS

Principal at Risk Securities

 

Russell 2000® Index Overview

Bloomberg Ticker Symbol: RTY

The Russell 2000® Index is an index that measures the capitalization-weighted price performance of 2,000 U.S. small-capitalization stocks listed on eligible U.S. exchanges. The underlying index publisher with respect to the Russell 2000® Index is FTSE International Limited, or any successor thereof. The Russell 2000® Index is designed to track the performance of the small-capitalization segment of the U.S. equity market. The companies included in the Russell 2000® Index are the middle 2,000 (i.e., those ranked 1,001 through 3,000) of the companies that form the Russell 3000E™ Index. The Russell 2000® Index represents approximately 7% of the U.S. equity market. For additional information about the Russell 2000® Index, see the information set forth under “Russell Indices—Russell 2000® Index” in the accompanying index supplement.

The closing level of the RTY Index on June 24, 2025 was 2,161.212. The following graph sets forth the daily closing levels of the underlier for the period noted below. We obtained the historical information presented in this document from Bloomberg Financial Markets, without independent verification. The underlier has at times experienced periods of high volatility. You should not take the historical closing levels of the underlier as an indication of its future performance, and no assurance can be given as to the closing level of the underlier at any time.

RTY Index Daily Closing Levels

January 1, 2020 to June 24, 2025

 Page 10

Morgan Stanley Finance LLC

Buffered PLUS

Principal at Risk Securities

 

Additional Terms of the Securities

Please read this information in conjunction with the terms on the cover of this document.

Additional Terms:

If the terms described herein are inconsistent with those described in the accompanying product supplement, index supplement or prospectus, the terms described herein shall control.

Denominations:

$1,000 per security and integral multiples thereof

Buffered PLUS:

The accompanying product supplement refers to these Buffered PLUS as the “securities.”

Amortization period:

The 6-month period following the issue date

Trustee:

The Bank of New York Mellon

Calculation agent:

Morgan Stanley & Co. LLC (“MS & Co.”)

 Page 11

Morgan Stanley Finance LLC

Buffered PLUS

Principal at Risk Securities

 

Additional Information About the Securities

Additional Information:

Minimum ticketing size:

$1,000 / 1 security

United States federal income tax considerations:

You should review carefully the section in the accompanying product supplement entitled “United States Federal Income Tax Considerations.” The following discussion, when read in combination with that section, constitutes the full opinion of our counsel, Davis Polk & Wardwell LLP, regarding the material U.S. federal income tax consequences of owning and disposing of the securities.

Generally, this discussion assumes that you purchased the securities for cash in the original issuance at the stated issue price and does not address other circumstances specific to you, including consequences that may arise due to any other investments relating to an underlier. You should consult your tax adviser regarding the effect any such circumstances may have on the U.S. federal income tax consequences of your ownership of a security.

In the opinion of our counsel, which is based on current market conditions, it is reasonable to treat the securities for U.S. federal income tax purposes as prepaid financial contracts that are “open transactions,” as described in the section entitled “United States Federal Income Tax Considerations—Tax Consequences to U.S. Holders—Securities Treated as Prepaid Financial Contracts that are Open Transactions” in the accompanying product supplement. There is uncertainty regarding this treatment, and the IRS or a court might not agree with it. Moreover, because this treatment of the securities and our counsel’s opinion are based on market conditions as of the date of this preliminary pricing supplement, each is subject to confirmation on the pricing date. A different tax treatment could be adverse to you. Generally, if this treatment is respected, (i) you should not recognize taxable income or loss prior to the taxable disposition of your securities (including upon maturity or an earlier redemption, if applicable) and (ii) the gain or loss on your securities should be treated as capital gain or loss.

We do not plan to request a ruling from the IRS regarding the treatment of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership and disposition of the securities, including the timing and character of income recognized. In addition, the U.S. Treasury Department and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of “prepaid forward contracts” and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance. Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive effect.

Non-U.S. Holders. As discussed under “United States Federal Income Tax Considerations—Tax Consequences to Non-U.S. Holders—Dividend Equivalents under Section 871(m) of the Code” in the accompanying product supplement, Section 871(m) of the Internal Revenue Code and Treasury regulations promulgated thereunder (“Section 871(m)”) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities or indices that include U.S. equities. The Treasury regulations, as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a “delta” of one. Based on certain determinations made by us, we expect that Section 871(m) will not apply to the securities with regard to Non-U.S. Holders. Our determination is not binding on the IRS, and the IRS may disagree with this determination. If necessary, further information regarding the potential application of Section 871(m) will be provided in the final pricing supplement for the securities.

We will not be required to pay any additional amounts with respect to U.S. federal withholding taxes.

You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments, as well as tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.

Additional considerations:

Client accounts over which Morgan Stanley, Morgan Stanley Wealth Management or any of their respective subsidiaries have investment discretion are not permitted to purchase the securities, either directly or indirectly.

Supplemental information regarding plan of distribution; conflicts of interest:

MS & Co. expects to sell all of the securities that it purchases from us to an unaffiliated dealer at a price of $ per security, for further sale to certain fee-based advisory accounts at the price to public of $1,000 per security. In addition, selected dealers and their financial advisors may receive a structuring fee of up to $6.25 for each security from the agent or its affiliates. MS & Co. will not receive a sales commission with respect to the securities.

MS & Co. is an affiliate of MSFL and a wholly owned subsidiary of Morgan Stanley, and it and other

 Page 12

Morgan Stanley Finance LLC

Buffered PLUS

Principal at Risk Securities

 

affiliates of ours expect to make a profit by selling, structuring and, when applicable, hedging the securities.

MS & Co. will conduct this offering in compliance with the requirements of FINRA Rule 5121 of the Financial Industry Regulatory Authority, Inc., which is commonly referred to as FINRA, regarding a FINRA member firm’s distribution of the securities of an affiliate and related conflicts of interest. MS & Co. or any of our other affiliates may not make sales in this offering to any discretionary account. See “Plan of Distribution (Conflicts of Interest)” and “Use of Proceeds and Hedging” in the accompanying product supplement.

Where you can find more information:

Morgan Stanley and MSFL have filed a registration statement (including a prospectus, as supplemented by the product supplement and the index supplement) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. You should read the prospectus in that registration statement, the product supplement, the index supplement and any other documents relating to this offering that MSFL and Morgan Stanley have filed with the SEC for more complete information about Morgan Stanley and this offering. When you read the accompanying index supplement, please note that all references in such supplement to the prospectus dated November 16, 2023, or to any sections therein, should refer instead to the accompanying prospectus dated April 12, 2024 or to the corresponding sections of such prospectus, as applicable. You may get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, MSFL, Morgan Stanley, any underwriter or any dealer participating in the offering will arrange to send you the prospectus, the index supplement and the product supplement if you so request by calling toll-free 1-(800)-584-6837.

Terms used but not defined in this document are defined in the product supplement, in the index supplement or in the prospectus. Each of the product supplement, the index supplement and the prospectus can be accessed via the hyperlinks set forth on the cover of this document.

“Performance Leveraged Upside SecuritiesSM” and “PLUSSM” are our service marks.

 

 Page 13

FAQ

What leverage factor will Morgan Stanley's Buffered PLUS (MS) use?

The leverage factor will be set on 31 July 2025 and is expected to fall between 163 % and 173 %.

How does the 10% buffer protect investors in the MS Buffered PLUS?

If the worst-performing index ends no more than 10 % below its initial level, investors receive full principal; losses begin only beyond that threshold.

What happens if any index falls more than 10% at maturity?

Repayment equals $1,000 × (performance factor + 10 %), causing a 1 : 1 loss beyond the buffer, with a minimum return of $100.

How does the estimated value compare with the $1,000 issue price?

Morgan Stanley estimates the value at approximately $962.10 on the pricing date, lower due to issuance, structuring and hedging costs.

Will the Buffered PLUS notes be listed on an exchange?

No, the securities will not be listed; any secondary trading will occur over-the-counter at MS &Co.'s discretion.

What credit risks do investors face with these MS securities?

The notes are unsecured, unsubordinated obligations; repayment depends on Morgan Stanley’s ability to meet its liabilities.
Morgan Stanley

NYSE:MS

MS Rankings

MS Latest News

MS Latest SEC Filings

MS Stock Data

218.03B
1.22B
23.64%
62.12%
0.89%
Capital Markets
Security Brokers, Dealers & Flotation Companies
United States
NEW YORK